Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,740 across all filing types
Latest filing 2024-11-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
113年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The presence of actual financial figures and the nature of the content indicate this is a financial report rather than an announcement or certification. The data is for the third quarter of the fiscal year 113 (Taiwan calendar), which corresponds to a quarterly period. Therefore, this document is best classified as an Interim / Quarterly Report (IR). The document length is 3906 characters, which is sufficient to contain substantive financial data, supporting this classification. 9M 2024
2024-11-12 Chinese
113年10月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report from a publicly listed company, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document is short (771 characters) and primarily provides financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is a regulatory disclosure of financial data, typical of a Regulatory Filing (RNS) category, as it does not fit the definitions of other specific report types and is more of a compliance disclosure.
2024-11-08 Chinese
113年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 華廣, providing information about fund loans and endorsement guarantees for the current and previous month, with zero balances reported. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not contain comprehensive financial results, management discussion, or regulatory certifications. It appears to be a routine regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing rather than a full report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2024-11-08 Chinese
公告本公司董事會通過113年度第三季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (華廣) reporting the board's approval of the consolidated financial report for the third quarter of the fiscal year 113 (covering 01/01 to 09/30). It includes cumulative financial figures such as revenue, gross profit, operating loss, net loss, EPS, total assets, liabilities, and equity. The document is short (914 characters) and primarily serves as an announcement of the board's approval of the quarterly financial report rather than the full detailed report itself. This fits the definition of an Interim / Quarterly Report (IR) because it contains substantive financial data for a period shorter than a full fiscal year. Therefore, the correct classification is IR with high confidence. 9M 2024
2024-11-06 Chinese
113年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It focuses on the number of shares held, pledged shares, and related percentages. There is no indication of financial results, earnings, management discussion, or meeting materials. The content is a report on insider shareholdings and pledging activity, which corresponds to disclosures about personal share transactions or holdings by company directors and executives. This matches the definition of Director's Dealing (DIRS). The document length is about 3,133 characters, which is sufficient for a detailed insider shareholding report rather than a brief announcement. Therefore, the appropriate classification is DIRS with high confidence.
2024-11-05 Chinese
113年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a detailed disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-11-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.